In This Article:
-
Net Sales: $374 million, a 15% decrease year over year.
-
Automotive Net Sales: $188 million, down 11% compared to the first quarter last year.
-
Medical Net Sales: $90 million, a 12% decrease compared to the same period last year.
-
Industrial Net Sales: $96 million, down 22% year over year.
-
Gross Margin Rate: 6.3%, a 180-basis point decline compared to the first quarter of fiscal 2024.
-
Adjusted Operating Income: $12.6 million or 3.4% of net sales.
-
Adjusted Net Income: $5.5 million or $0.22 per diluted share.
-
Cash and Cash Equivalents: $76.6 million as of September 30, 2024.
-
Cash Flow from Operating Activities: $45.5 million.
-
Inventory Reduction: $147 million or 30% reduction compared to Q1 last year.
-
Borrowings on Credit Facility: $245.9 million, a $48.9 million reduction from last quarter.
-
Fiscal Year 2025 Guidance: Net sales expected to be in the range of $1.44 billion to $1.54 billion.
Release Date: November 05, 2024
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Positive Points
-
Kimball Electronics Inc (NASDAQ:KE) has strategically restructured by divesting non-core businesses and focusing on key growth areas within the medical vertical.
-
The company has sharpened its strategic focus across its three vertical markets, targeting attractive new market spaces such as automotive domain controllers and energy storage solutions.
-
Kimball Electronics Inc (NASDAQ:KE) has been proactive in adjusting resources and costs to align with ongoing market demand, which is expected to benefit the company as demand stabilizes.
-
The company has successfully reduced inventory levels by over $150 million, generating significant positive cash flow and reducing debt to a two-year low.
-
Kimball Electronics Inc (NASDAQ:KE) announced the closure of its Tampa manufacturing facility to streamline operations and improve efficiency, with plans to transfer production to other facilities, enhancing competitiveness.
Negative Points
-
Net sales for the first quarter decreased by 15% year over year, with declines across all three verticals: automotive, medical, and industrial.
-
The automotive segment experienced an 11% decline in net sales due to volume softening and overstocking, particularly in Europe and North America.
-
The medical segment saw a 12% decrease in net sales, heavily impacted by volume declines in Asia due to excess inventory.
-
The industrial segment reported a 22% decline in net sales, with significant decreases in North America and Europe due to weak demand for certain products.
-
Gross margin rate declined by 180 basis points compared to the previous year, primarily due to lower absorption from declining sales.